Cargando…

Investing in non-communicable disease risk factor control among adolescents worldwide: a modelling study

INTRODUCTION: Exposure to non-communicable disease (NCD) risk factors is increasing among adolescents in most countries due to demographic, economic and epidemiological forces. We sought to analyse the potential health impact and costs of implementing NCD risk reduction interventions among adolescen...

Descripción completa

Detalles Bibliográficos
Autores principales: Watkins, David, Hale, Jessica, Hutchinson, Brian, Kataria, Ishu, Kontis, Vasilis, Nugent, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509594/
https://www.ncbi.nlm.nih.gov/pubmed/31139451
http://dx.doi.org/10.1136/bmjgh-2018-001335
_version_ 1783417274193936384
author Watkins, David
Hale, Jessica
Hutchinson, Brian
Kataria, Ishu
Kontis, Vasilis
Nugent, Rachel
author_facet Watkins, David
Hale, Jessica
Hutchinson, Brian
Kataria, Ishu
Kontis, Vasilis
Nugent, Rachel
author_sort Watkins, David
collection PubMed
description INTRODUCTION: Exposure to non-communicable disease (NCD) risk factors is increasing among adolescents in most countries due to demographic, economic and epidemiological forces. We sought to analyse the potential health impact and costs of implementing NCD risk reduction interventions among adolescents worldwide. METHODS: We identified six interventions targeted at adolescent tobacco smoking, heavy episodic drinking and obesity and supported by effectiveness and cost-effectiveness evidence. Based on a population-level cohort of adolescents in 70 representative countries, we assessed the global mortality consequences of fully implementing these interventions over 2020–2070 using the potential impact fraction approach. We calculated the economic benefits of reduced mortality and estimated the required financial costs, discounting both at 3% annually. We also conducted best-case and worst-case scenario analyses. RESULTS: Full implementation of these interventions worldwide could avert nearly 10% of premature deaths among this cohort, translating to about US$400 billion in cumulative economic benefits. Cumulatively, the required costs would be about US$85 billion, suggesting that every US$1 of public money invested would generate US$5 in increased human capital. Tobacco taxes generally conferred the highest economic returns; however, an in-depth analysis of three countries illustrated the potential for different priorities, such as alcohol control, to emerge. CONCLUSION: From a life course perspective, implementation of a package of interventions to reduce NCD risk among adolescents worldwide would substantially reduce premature mortality at reasonable costs. Our analysis illustrates the importance of integrating NCD prevention policies into the emerging global agenda for adolescent health and well-being.
format Online
Article
Text
id pubmed-6509594
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-65095942019-05-28 Investing in non-communicable disease risk factor control among adolescents worldwide: a modelling study Watkins, David Hale, Jessica Hutchinson, Brian Kataria, Ishu Kontis, Vasilis Nugent, Rachel BMJ Glob Health Research INTRODUCTION: Exposure to non-communicable disease (NCD) risk factors is increasing among adolescents in most countries due to demographic, economic and epidemiological forces. We sought to analyse the potential health impact and costs of implementing NCD risk reduction interventions among adolescents worldwide. METHODS: We identified six interventions targeted at adolescent tobacco smoking, heavy episodic drinking and obesity and supported by effectiveness and cost-effectiveness evidence. Based on a population-level cohort of adolescents in 70 representative countries, we assessed the global mortality consequences of fully implementing these interventions over 2020–2070 using the potential impact fraction approach. We calculated the economic benefits of reduced mortality and estimated the required financial costs, discounting both at 3% annually. We also conducted best-case and worst-case scenario analyses. RESULTS: Full implementation of these interventions worldwide could avert nearly 10% of premature deaths among this cohort, translating to about US$400 billion in cumulative economic benefits. Cumulatively, the required costs would be about US$85 billion, suggesting that every US$1 of public money invested would generate US$5 in increased human capital. Tobacco taxes generally conferred the highest economic returns; however, an in-depth analysis of three countries illustrated the potential for different priorities, such as alcohol control, to emerge. CONCLUSION: From a life course perspective, implementation of a package of interventions to reduce NCD risk among adolescents worldwide would substantially reduce premature mortality at reasonable costs. Our analysis illustrates the importance of integrating NCD prevention policies into the emerging global agenda for adolescent health and well-being. BMJ Publishing Group 2019-04-25 /pmc/articles/PMC6509594/ /pubmed/31139451 http://dx.doi.org/10.1136/bmjgh-2018-001335 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Research
Watkins, David
Hale, Jessica
Hutchinson, Brian
Kataria, Ishu
Kontis, Vasilis
Nugent, Rachel
Investing in non-communicable disease risk factor control among adolescents worldwide: a modelling study
title Investing in non-communicable disease risk factor control among adolescents worldwide: a modelling study
title_full Investing in non-communicable disease risk factor control among adolescents worldwide: a modelling study
title_fullStr Investing in non-communicable disease risk factor control among adolescents worldwide: a modelling study
title_full_unstemmed Investing in non-communicable disease risk factor control among adolescents worldwide: a modelling study
title_short Investing in non-communicable disease risk factor control among adolescents worldwide: a modelling study
title_sort investing in non-communicable disease risk factor control among adolescents worldwide: a modelling study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509594/
https://www.ncbi.nlm.nih.gov/pubmed/31139451
http://dx.doi.org/10.1136/bmjgh-2018-001335
work_keys_str_mv AT watkinsdavid investinginnoncommunicablediseaseriskfactorcontrolamongadolescentsworldwideamodellingstudy
AT halejessica investinginnoncommunicablediseaseriskfactorcontrolamongadolescentsworldwideamodellingstudy
AT hutchinsonbrian investinginnoncommunicablediseaseriskfactorcontrolamongadolescentsworldwideamodellingstudy
AT katariaishu investinginnoncommunicablediseaseriskfactorcontrolamongadolescentsworldwideamodellingstudy
AT kontisvasilis investinginnoncommunicablediseaseriskfactorcontrolamongadolescentsworldwideamodellingstudy
AT nugentrachel investinginnoncommunicablediseaseriskfactorcontrolamongadolescentsworldwideamodellingstudy